Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × Interleukin-2 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 7 Breast Neoplasms 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Skin Neoplasms 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid 2 Leukemia 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Merkel Cell 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Select Advanced Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma 1

Interventions

Magnetic Resonance Spectroscopy 20 Temozolomide 14 Radiotherapy 9 Specimen Handling 7 Radiation 6 Blood Specimen Collection 6 Bevacizumab 4 trametinib 3 pembrolizumab 3 Surgical Procedures, Operative 3 Nivolumab 3 Drug Therapy 3 Cyclophosphamide 3 Biopsy 3 vorasidenib 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 fluciclovine F-18 2 dabrafenib 2 X-Rays 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Magnetic Resonance Imaging 2 Infusions, Intravenous 2 Genetic Testing 2 Everolimus 2 Etoposide 2 Elasticity Imaging Techniques 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡